Surgical Robots Market Size, Share & Trends Analysis Report By Application (Urology, Orthopedics, Neurology, Gynecology), By End Use (Inpatient, Outpatient), By Region, And Segment Forecasts, 2025 - 2033

Surgical Robots Market Summary

The global surgical robots market size was estimated at USD 4.31 billion in 2024 and projected to reach USD 9.60 billion by 2033, growing at a CAGR of 9.26% from 2025 to 2033. The global shortage of physicians and surgeons, with growing adoption of automated surgical instruments, significantly contributes to market expansion.

Technological advancements, increased investments from regional and international stakeholders, and the rising prevalence of chronic diseases, particularly in knee and hip replacement surgeries, are key drivers of this market growth. In March 2025, according to the American College of Rheumatology, over 790,000 knee and 544,000 hip replacements are performed annually in the U.S., reflecting a steady increase as the population ages.

The rising prevalence of joint-related health issues and an aging population is driving demand for orthopedic procedures. Growing patient expectations for quicker recovery and improved mobility further strengthen the need for advanced and effective treatment solutions. In November 2024, as per the American Academy of Orthopedic Surgeons (AAOS) study, over 3.7 million total hip and knee replacement surgeries took place at 1,447 facilities across all 50 states and the District of Columbia during the period from 2012 to 2023.

Advantages associated with these medical procedures include less pain & blood loss, shorter recovery period, lower risk of infections at the site, and smaller or less noticeable scars, aiding market growth. For instance, according to a study published by the Hip and Knee Society comparing the 90-day care costs between patients who received a Mako total knee replacement and patients who underwent conventional knee surgery, the cost of care for patients receiving treatment using Mako was USD 2,400 less than that for those patients who received conventional knee replacement. The study revealed that a reduction of 33% in 90-day readmissions was observed in patients receiving treatment using Mako.

The increasing prevalence of bone degenerative diseases, such as arthritis and osteoporosis, is driving a surge in hip and knee replacement surgeries, significantly impacting market growth. Osteoporosis impacts around 10 million individuals in the U.S., and approximately 75 million people across the U.S., Europe, and Japan collectively. Projections suggest that by 2040, 1 in 4 U.S. adults (78.4 million) will have doctor-diagnosed arthritis, and 1 in 9 adults (34.6 million) will experience arthritis-attributable activity limitations. As the demand for joint replacement procedures rises, advancements in robotic-assisted surgery are transforming the orthopedic landscape by improving precision, reducing recovery times, and enhancing patient outcomes.

The increasing demand for advanced medical technologies is reshaping the healthcare landscape. In particular, the operational sector is adopting innovative solutions to enhance patient outcomes and streamline procedures.With ongoing advancements, healthcare providers are better equipped to address complex medical challenges and improve overall efficiency. For instance, a report from the World Health Organization in February 2024 highlighted that there were over 20 million new cancer cases worldwide, with 53.5 million individuals surviving at least five years of post-diagnosis.

Global Surgical Robots Market Segmentation

This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global surgical robots market report based on application, end use, and region:

• Application Outlook (Procedure Volume (Surgeries Performed, 000); Unit Volume (Systems Installed, 000); Revenue, USD Million, 2021 - 2033)
• Orthopedics
• Hip
• Knee
• Spine
• Others
• Urology
• General Surgery
• Gynecology
• Cardiothoracic
• Neurosurgery
• ENT (Otolaryngology)
• Bariatric / Metabolic
• Others
• End Use Outlook (Procedure Volume (Surgeries Performed, 000); Unit Volume (Systems Installed, 000); Revenue, USD Million, 2021 - 2033)
• Inpatient
• Outpatient
• Regional Outlook (Procedure Volume (Surgeries Performed, 000); Unit Volume (Systems Installed, 000); Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification. Show more